Source: Annual Congress 2003 - Models of immune responses and airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Ito, A. Kanehiro, K. Matsumoto, M. Ohmori, M. Kataoka, T. Nakamura, M. Tanimoto (Okayama, Osaka, Japan). Hepatocyte growth factor prevents airway remodelling in asthma. Eur Respir J 2003; 22: Suppl. 45, 1310

Member's Comments

No comment yet.

Related content which might interest you: Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Fibroblast growth factor 23 and Klotho contribute to airway inflammation Source: Eur Respir J, 52 (1) 1800236; 10.1183/13993003.00236-2018 Year: 2018 The contribution of transforming growth factor-β and epidermal growth factor signalling to airway remodelling in chronic asthma Source: Eur Respir J 2006; 27: 208-229 Year: 2006 Transforming growth factor alpha produces airway remodelling and reduces airway distensibility Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004 Connective tissue growth factor and transforming growth factor β induces extracellular matrix in asthmatic airway smooth muscle Source: Eur Respir J 2005; 26: Suppl. 49, 712s Year: 2005 Hepatocyte growth factor – a link between neutrophilic inflammation and BOS? Source: Eur Respir J 2006; 28: Suppl. 50, 120s Year: 2006 PP113 – Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood? Source: ERS Lung Science Conference 2021 Year: 2021 Keratinocyte growth factor improves alterations of lung permeability and bronchial epithelium in allergic rats Source: Eur Respir J 2007; 30: 31-39 Year: 2007 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma Source: Eur Respir J 2003; 21: 804-809 Year: 2003 Pseudomonas aeruginosa induces vascular endothelial growth factor synthesis in airway epithelium in vitro and in vivo Source: Eur Respir J 2011; 38: 939-946 Year: 2011 PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005 CFTR dysfunction induces vascular endothelial growth factor synthesis in airway epithelium Source: Eur Respir J 2013; 42: 1553-1562 Year: 2013 Oxygen desaturation is associated with fibrocyte activation via epidermal growth factor receptor/hypoxia-inducible factor(HIF)-1a axis in COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 The epidermal growth factor receptor mediates allergic airway remodelling in the rat Source: Eur Respir J 2008; 32: 1213-1223 Year: 2008 Nerve growth factor levels and localisation in human asthmatic bronchi Source: Eur Respir J 2002; 20: 1110-1116 Year: 2002 LSC - 2021 - Epidermal growth factor receptor in airway remodelling during allergic airway disease – divergent roles during early life and adulthood? Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021